Mansfield C, Sutphin J, Boeri M. Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow-up question. Health Econ. 2020 Oct;29(10):1307-15. doi: 10.1002/hec.4124
Heidenreich S, Watson V, Ryan M, Phimister E. Decision heuristic or preference? Attribute non-attendance in discrete choice problems. Health Econ. 2018 Jan;27(1):157-71. doi: 10.1002/hec.3524
Tsuchiya A, Watson V. Re-thinking “the different perspectives that can be used when eliciting preferences in health". Health Econ. 2017 Dec;26(12):e103-7. doi: 10.1002/hec.3480
Krucien N, Watson V, Ryan M. Is best-worst scaling suitable for health state valuation? A comparison with discrete choice experiments. Health Econ. 2017 Dec;26(12):e1-e16. doi: 10.1002/hec.3459
Watson V, Becker F, de Bekker-Grob E. Discrete choice experiment response rates: a meta-analysis. Health Econ. 2017 Jun;26(6):810-7. doi: 10.1002/hec.3354
Sauchelli S, Arcelus J, Sanchez I, Riesco N, Jimenez-Murcia S, Granero R, Gunnard K, Banos R, Botella C, de la Torre R, Fernandez-Garcia JC, Fernandez-Real JM, Fruhbeck G, Gomez-Ambrosi J, Tinahones FJ, Casanueva FF, Menchon JM, Fernandez-Aranda F. Physical activity in anorexia nervosa: how relevant is it to therapy response? Eur Psychiatry. 2015 Nov;30(8):924-31. doi: 10.1016/j.eurpsy.2015.09.008
Zarkin GA, Cowell AJ, Hicks KA, Mills MJ, Belenko S, Dunlap LJ, Houser KA, Keyes V. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ. 2012 Jun;21(6):633-52.
Ryan M, Watson V. Comparing welfare estimates from payment card contingent valuation and discrete choice experiments. Health Econ. 2009 Apr;18(4):389-401. doi: 10.1002/hec.1364
Ryan M, Watson V, Entwistle V. Rationalising the 'irrational': a think aloud study of discrete choice experiment responses. Health Econ. 2009 Mar;18(3):321-36. doi: 10.1002/hec.1369
Plaza A, Navarro P, Garcia-Esteve LL, Ascaso C, Aguado J, Martin-Santos R. Pospartum depression and early life events: influences of the dysregulation of the pituitary-thyroid axis. Poster presented at the 15th AEP Congress; March 19, 2007. Madrid, Spain. [abstract] Eur Psychiatry. 22(Suppl 1):S243. doi: 10.1016/j.eurpsy.2007.01.812
Navarro P, Garcia-Esteve LL, Ascaso C, Aguado J, Martin-Santos R. Prevalence of postnatal psychiatric morbidity: a preliminary analysis. Poster presented at the 15th AEP Congress; March 2007. Madrid, Spain. [abstract] Eur Psychiatry. 2007 Mar; 22(Suppl 1):S328-9. doi: 10.1016/j.eurpsy.2007.01.1095
Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005 Nov 1;14(11):1133-50.
Garcia-Esteve LL, Navarro P, Ascaso C, Aguado JA, Plaza A, Torres A. Prevalence of postpartum psychiatric morbidity in Spanish mothers. Poster presented at the 12th AEP Congress; April 14, 2004. Geneva, Switzerland. [abstract] Eur Psychiatry. 2004 Apr; 19(Suppl 1):209S.
Garcia-Esteve LL, Navarro P, Ascaso C, Aguado JA, Unizony M, Matrai S. Validation of the Edinburgh Postnatal Depression Scale (EPDS) for detection of postpartum psychiatric morbidity in Spanish mothers. Poster presented at the 12th AEP Congress; April 2004. Geneva, Switzerland. [abstract] Eur Psychiatry. 2004 Apr; 19(Suppl 1):208S-9S.
McKenna SP, Whalley D. Can quality of life scales tell us when patients begin to feel the benefits of antidepressants? Eur Psychiatry. 1998 May;13(3):146-53.
Clarkson T, Anthony MS, Hughes C. Estrogenic soybean isoflavones and chronic disease: risks and benefits. Trends Endocrinol Metab. 1995 Jan;6(1):11-6.